Who has invested in Apnimed?

Morningside, Sectoral, Alpha Wave Global are named among the investors backing Apnimed.

Apnimed Funding: $249M Raised, Series C (2023)

Apnimed funding overview

Apnimed is based in Cambridge. Apnimed has raised $249M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2023. The round record for Apnimed runs through 2023; nothing later has been disclosed. Investors on record include Morningside, Sectoral, Alpha Wave Global. 3 distinct backers are named across the disclosed rounds.

Apnimed at a glance

Total raised: $249M
Latest round: Series C
Latest round date: May 2023
Headquarters: Cambridge
Notable investors: Morningside, Sectoral, Alpha Wave Global

Frequently asked about Apnimed funding

How much has Apnimed raised?: Apnimed has raised $249M in total disclosed funding across the rounds on record.
Who has invested in Apnimed?: Morningside, Sectoral, Alpha Wave Global are named among the investors backing Apnimed.
What was the latest Apnimed funding round?: The most recent disclosed round is a Series C, announced in May 2023.
Where is Apnimed based?: Apnimed is based in Cambridge.
When did Apnimed last raise?: The last disclosed Apnimed round closed in May 2023 at Series C.

Totals shown for Apnimed aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

Apnimed Funding: $249M Raised, Series C (2023)

Apnimed funding overview

Apnimed at a glance

Frequently asked about Apnimed funding

Companies related to Apnimed (35)

Browse related funding lists (7)